Literature DB >> 10666277

Elevated serum transforming growth factor beta1 levels in Epstein-Barr virus-associated diseases and their correlation with virus-specific immunoglobulin A (IgA) and IgM.

J Xu1, A Ahmad, J F Jones, R Dolcetti, E Vaccher, U Prasad, J Menezes.   

Abstract

Transforming growth factor beta (TGF-beta) is an immunosuppressive cytokine which can induce immunoglobulin A (IgA) switch and Epstein-Barr virus (EBV) replication in latently infected cells. Here we report elevated serum levels of TGF-beta in various EBV-associated diseases correlating positively with EBV-specific IgA titers and negatively with IgM titers, suggesting a role for this cytokine in the pathogenesis of these diseases.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10666277      PMCID： PMC111728          DOI： 10.1128/jvi.74.5.2443-2446.2000

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


  26 in total

Review 1.  Epstein-Barr virus vaccines.

Authors:  A J Morgan
Journal:  Vaccine       Date:  1992       Impact factor: 3.641

2.  Immunoglobulin A-induced shift of Epstein-Barr virus tissue tropism.

Authors:  J W Sixbey; Q Y Yao
Journal:  Science       Date:  1992-03-20       Impact factor: 47.728

Review 3.  Receptors for the TGF-beta family.

Authors:  J Massagué
Journal:  Cell       Date:  1992-06-26       Impact factor: 41.582

4.  Epstein-Barr virus mediates a switch in responsiveness to transforming growth factor, type beta, in cells of the B cell lineage.

Authors:  H K Blomhoff; E Smeland; A S Mustafa; T Godal; R Ohlsson
Journal:  Eur J Immunol       Date:  1987-02       Impact factor: 5.532

5.  Detection of IgA antibody to EBV membrane antigen using Staphylococcus aureus preabsorbed sera is closely associated with nasopharyngeal carcinoma.

Authors:  G H Pi; Y Zeng; H Wolf
Journal:  J Virol Methods       Date:  1987-01       Impact factor: 2.014

6.  Nasopharyngeal carcinoma: immunohistochemical study for keratin, secretory component and leukocyte common antigen.

Authors:  H Nomori; T Kameya; Y Shimosato; H Saito; S Ebihara; I Ono
Journal:  Jpn J Clin Oncol       Date:  1985-03       Impact factor: 3.019

7.  Elevated serum levels of transforming growth factor beta1 in Epstein-Barr virus-associated nasopharyngeal carcinoma patients.

Authors:  J Xu; J Menezes; U Prasad; A Ahmad
Journal:  Int J Cancer       Date:  1999-08-20       Impact factor: 7.396

Review 8.  Epstein-Barr virus and human diseases: recent advances in diagnosis.

Authors:  M Okano; G M Thiele; J R Davis; H L Grierson; D T Purtilo
Journal:  Clin Microbiol Rev       Date:  1988-07       Impact factor: 26.132

9.  Salivary and serum IgA antibodies to the Epstein-Barr virus glycoprotein gp340: incidence and potential for virus neutralization.

Authors:  Q Y Yao; M Rowe; A J Morgan; C K Sam; U Prasad; H Dang; Y Zeng; A B Rickinson
Journal:  Int J Cancer       Date:  1991-04-22       Impact factor: 7.396

Review 10.  Interleukin-10.

Authors:  K W Moore; A O'Garra; R de Waal Malefyt; P Vieira; T R Mosmann
Journal:  Annu Rev Immunol       Date:  1993       Impact factor: 28.527
View more
  8 in total

1.  Alpha/beta and gamma interferons are induced by infection with noncytopathic bovine viral diarrhea virus in vivo.

Authors:  B Charleston; L S Brackenbury; B V Carr; M D Fray; J C Hope; C J Howard; W I Morrison
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

2.  TGF-beta1 suppresses T cell infiltration and VP2 puff B mutation enhances apoptosis in acute polioencephalitis induced by Theiler's virus.

Authors:  Ikuo Tsunoda; Jane E Libbey; Robert S Fujinami
Journal:  J Neuroimmunol       Date:  2007-09-04       Impact factor: 3.478

3.  Latent membrane protein 2A inhibits transforming growth factor-beta 1-induced apoptosis through the phosphatidylinositol 3-kinase/Akt pathway.

Authors:  Makoto Fukuda; Richard Longnecker
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

4.  Human Leukocyte Antigen (HLA) A*1101-Restricted Epstein-Barr Virus-Specific T-cell Receptor Gene Transfer to Target Nasopharyngeal Carcinoma.

Authors:  Yong Zheng; Greg Parsonage; Xiaodong Zhuang; Lee R Machado; Christine H James; Asmaa Salman; Peter F Searle; Edwin P Hui; Anthony T C Chan; Steven P Lee
Journal:  Cancer Immunol Res       Date:  2015-02-24       Impact factor: 11.151

5.  Novel mouse xenograft models reveal a critical role of CD4+ T cells in the proliferation of EBV-infected T and NK cells.

Authors:  Ken-ichi Imadome; Misako Yajima; Ayako Arai; Atsuko Nakazawa; Fuyuko Kawano; Sayumi Ichikawa; Norio Shimizu; Naoki Yamamoto; Tomohiro Morio; Shouichi Ohga; Hiroyuki Nakamura; Mamoru Ito; Osamu Miura; Jun Komano; Shigeyoshi Fujiwara
Journal:  PLoS Pathog       Date:  2011-10-20       Impact factor: 6.823

6.  Assessment of immunological changes in Epstein-Barr virus co-infection in Egyptian chronic HCV patients.

Authors:  Sahar Shoman; Mohamed Nabil; Ashraf Tabl; Hussam Ghanem; Sherif El Kafrawy
Journal:  Mem Inst Oswaldo Cruz       Date:  2014-08-22       Impact factor: 2.743

7.  High FMNL3 expression promotes nasopharyngeal carcinoma cell metastasis: role in TGF-β1-induced epithelia-to-mesenchymal transition.

Authors:  Yanxia Wu; Zhihua Shen; Keke Wang; Yanping Ha; Hong Lei; Yanan Jia; Ranran Ding; Dongmei Wu; Siyuan Gan; Rujia Li; Botao Luo; Hanguo Jiang; Wei Jie
Journal:  Sci Rep       Date:  2017-02-15       Impact factor: 4.379

8.  The Binary Classification Of Chronic Diseases.

Authors:  Zeev Elkoshi
Journal:  J Inflamm Res       Date:  2019-12-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.